Cell News and Research

RSS

Age and immunity: study highlights challenges and opportunities for vaccine protection

Scientists have evaluated molecular mechanisms responsible for heterogeneous responses to influenza vaccination among older adults.

17 Jul 2023

MGI empowers life cienss industry with revolutionary what if campaign at XXIIIrd International Congress of Genetics

MGI Tech Co. Ltd. (MGI), a company committed to building core tools and technology to lead life science, today announced the launch of a global brand campaign titled “What If?” at the XXIII International Congress of Genetics (ICG), a five-yearly conference to bring together the international genetics community from around the world.

From MGI 17 Jul 2023

The prognostic value of PCSK9 levels for predicting major adverse cardiovascular events and mortality in diabetics

Researchers investigate the prognostic value of PCSK9 levels in diabetes patients to predict all-cause mortality and major adverse cardiovascular events.

17 Jul 2023

Breast cancer and MEN1: exploring the connection

Researchers evaluated the role of Multiple Endocrine Neoplasia 1 (MEN1) messenger ribonucleic acid (mRNA) in breast cancer

17 Jul 2023

Understanding the impact of HPV on the vaginal microbiome and its role in cervical cancer

Researchers determine whether cervical cancer risk could be assessed using microflora-derived metabolites in HPV-infected females.

17 Jul 2023

Boosted immunity: Delta and Omicron-BA.1 infections enhance protection in vaccinated patients

Researchers examined the immune response and potential cross-protection in hospitalized patients with breakthrough infections.

17 Jul 2023

Innovative mixed reality training platform to be developed for pharmaceutical companies and healthcare

UK immersive technology company FourPlus, along with collaborators Holosphere and the Cell and Gene Therapy Catapult, have been awarded funding from Innovate UK to create and test a mixed reality training platform that enables customised training delivery for pharmaceutical companies and healthcare.

17 Jul 2023

Healthy breast fat may protect against invasive breast cancer

Researchers have found a possible explanation as to why higher breast density and older age increase the risk of breast cancer.

17 Jul 2023

Stable nanoparticles train the immune system to fight cancer

Over the past decade, researchers have sought more effective and enduring cancer treatments. Among the wide variety of immunotherapies, Stimulator of Interfron Genes activation (STING agonism) has emerged as a particularly promising approach that harnesses a patient’s immune system to combat tumors throughout the body.

17 Jul 2023

Study describes the scope and integration of music therapy program within UH medical centers

A new study from University Hospitals (UH) Connor Whole Health describes the scope and integration of their music therapy program within10 UH medical centers.

14 Jul 2023

Aerobic glycolysis essential for eye development in mammals, study finds

Aerobic glycolysis, the process by which cells transform glucose into lactate, is key for eye development in mammals, according to a new Northwestern Medicine study published in Nature Communications.

14 Jul 2023

Gender, socioeconomic factors, and race/ethnicity linked to comorbidities among smokers with HIV

High rates of smoking among people with HIV are associated with high rates of comorbid health problems – which are associated with characteristics including gender, race/ethnicity, and socioeconomic status, according to a study in the July issue of The Journal of the Association of Nurses in AIDS Care.

14 Jul 2023

m6A modification as a potential therapeutic target for autoimmune diseases

N6-methyladenosine (m6A) is the most extensive studied RNA modification across various species, and the important effect of m6A modification in immune system has been revealed in distinct contexts, including mRNA metabolism, cell differentiation, proliferation and response to stimulation.

14 Jul 2023

Insilico Medicine and MIKADO team up to find new treatments for cystinosis

A team led by researchers at the Mechanisms of Inherited Kidney Disorders (MIKADO) group at the University of Zurich (Zurich, Switzerland) has used Insilico Medicine's generative artificial intelligence (AI) target discovery engine, PandaOmics, to identify actionable drug targets for the lysosomal storage disease cystinosis and to validate them in preclinical models of the disease.

14 Jul 2023

Researcher receives $2.7 million grant to study lingering Lyme disease symptoms

An estimated 1,200 Americans, on average, are diagnosed with Lyme disease each day. Some of those patients continue to experience negative effects, even after treatment.

14 Jul 2023

Primate brain cell atlas provides molecular and cellular basis for neural circuit research

A team of nearly 100 scientists recently mapped the cell-type taxonomy in the macaque cortex and revealed the relationship between cell-type composition and various primate brain regions by using the self-developed spatial transcriptome sequencing technology Stereo-seq and snRNA-seq technology, which provides a molecular and cellular basis for further investigation into neural circuits.

14 Jul 2023

New lipid 'signature' could help identify women at risk of preeclampsia

University of Virginia School of Medicine researchers have discovered a way to identify pregnant women at risk of preeclampsia, a serious disorder characterized by high blood pressure and kidney dysfunction which can result in premature delivery, seizures and even death.

14 Jul 2023

AI-powered drug discovery offers hope for cystinosis patients

Artificial intelligence is becoming increasingly important in drug discovery. Advances in the use of Big Data, learning algorithms and powerful computers have now enabled researchers at the University of Zurich (UZH) to better understand a serious metabolic disease.

14 Jul 2023

Australian researchers discover how COVID-19 can infect the human placenta

In a landmark study published in Nature Cell Biology, Australian researchers, led by Professor Jose Polo from Monash University and the University of Adelaide and University of Melbourne's Professor Kanta Subbarao from the Peter Doherty Institute for Infection and Immunity (Doherty Institute), have revealed how COVID-19 can infect the human placenta.

14 Jul 2023

New drug could overcome resistance to CDK4/6 inhibitors in breast cancer

Brest cancer is the most common cancer in women. Among breast tumors that spread to other organs (develop metastasis), 70% belong to a variant, called luminal, whose cells are sensitive to the female sex hormones estrogen and progesterone. In fact, the tumor forms when these hormones order the cells to divide.

14 Jul 2023

Cell News and Research

Age and immunity: study highlights challenges and opportunities for vaccine protection

MGI empowers life cienss industry with revolutionary what if campaign at XXIIIrd International Congress of Genetics

The prognostic value of PCSK9 levels for predicting major adverse cardiovascular events and mortality in diabetics

Breast cancer and MEN1: exploring the connection

Understanding the impact of HPV on the vaginal microbiome and its role in cervical cancer

Boosted immunity: Delta and Omicron-BA.1 infections enhance protection in vaccinated patients

Innovative mixed reality training platform to be developed for pharmaceutical companies and healthcare

Healthy breast fat may protect against invasive breast cancer

Stable nanoparticles train the immune system to fight cancer

Study describes the scope and integration of music therapy program within UH medical centers

Aerobic glycolysis essential for eye development in mammals, study finds

Gender, socioeconomic factors, and race/ethnicity linked to comorbidities among smokers with HIV

m6A modification as a potential therapeutic target for autoimmune diseases

Insilico Medicine and MIKADO team up to find new treatments for cystinosis

Researcher receives $2.7 million grant to study lingering Lyme disease symptoms

Primate brain cell atlas provides molecular and cellular basis for neural circuit research

New lipid 'signature' could help identify women at risk of preeclampsia

AI-powered drug discovery offers hope for cystinosis patients

Australian researchers discover how COVID-19 can infect the human placenta

New drug could overcome resistance to CDK4/6 inhibitors in breast cancer

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo